Author:
McCahill A. C.,Huston E.,Li X.,Houslay M. D.
Publisher
Springer Berlin Heidelberg
Reference203 articles.
1. Adessi C, Soto C (2002) Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 9:963–978
2. Ariga M, Neitzert B, Nakae S, Mottin G, Bertrand C, Pruniaux MP, Jin SL, Conti M (2004) Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. J Immunol 173:7531–7538
3. Alvarez R, Sette C, Yang D, Eglen RM, Wilhelm R, Shelton ER, Conti M (1995) Activation and selective inhibition of camp specific phosphodiesterases, PDE4D3. Mol Pharmacol 48:616–622
4. Baillie GS, Houslay MD (2005) Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol 17:129–134
5. Baillie GS, Mackenzie SJ, Houslay MD (2001) PMA triggers the PKA-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving Extracellular Signal Regulated Kinase (ERK). Mol Pharmacol 60:1100–1111
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献